These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25074956)

  • 21. Ambulatory care pharmacy services: the incomplete agenda.
    Carter BL; Helling DK
    Ann Pharmacother; 1992 May; 26(5):701-8. PubMed ID: 1591435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacists' perceptions of pay for performance versus fee-for-service remuneration for the management of hypertension through pharmacist prescribing.
    Rosenthal MM; Desai N; Houle SKD
    Int J Pharm Pract; 2017 Oct; 25(5):388-393. PubMed ID: 28097711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of medication-related problems and health care provider acceptance of pharmacist recommendations in the DiabetesCARE program.
    DeName B; Divine H; Nicholas A; Steinke DT; Johnson CL
    J Am Pharm Assoc (2003); 2008; 48(6):731-6. PubMed ID: 19019801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implementing primary care pharmacist services: Go upstream in the world of value-based payment models.
    Smith MA
    Res Social Adm Pharm; 2017; 13(5):892-895. PubMed ID: 28214149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of pharmacists' barriers to the implementation of medication therapy management services.
    Lounsbery JL; Green CG; Bennett MS; Pedersen CA
    J Am Pharm Assoc (2003); 2009; 49(1):51-8. PubMed ID: 19196597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Academic pharmacy and patient-centered health care: a model to prepare the next generation of pharmacists.
    Haines SL; DeHart RM; Flynn AA; Hess KM; Marciniak MW; Mount J; Phillips BB; Saseen JJ; Zatzkin SW
    J Am Pharm Assoc (2003); 2011; 51(2):194-202. PubMed ID: 21382810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specialty pharmacies and other restricted drug distribution systems: financial and safety considerations for patients and health-system pharmacists.
    Kirschenbaum BE
    Am J Health Syst Pharm; 2009 Dec; 66(24 Suppl 7):S13-20. PubMed ID: 19966075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expanding Ambulatory Care Pharmacy Residency Education Through a Multisite University-Affiliated Model.
    Schweiss SK; Westberg SM; Moon JY; Sorensen TD
    J Pharm Pract; 2017 Dec; 30(6):643-649. PubMed ID: 28110618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacist provider status legislation: Projections and prospects.
    Harper PC
    J Am Pharm Assoc (2003); 2015; 55(2):203-7. PubMed ID: 25749265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Organizational factors influencing pharmacy practice change.
    Doucette WR; Nevins JC; Gaither C; Kreling DH; Mott DA; Pedersen CA; Schommer JC
    Res Social Adm Pharm; 2012; 8(4):274-84. PubMed ID: 21958467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mapping the route to medication therapy management documentation and billing standardization and interoperabilility within the health care system: meeting proceedings.
    Millonig MK
    J Am Pharm Assoc (2003); 2009; 49(3):372-82. PubMed ID: 19357067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Projection of future pharmacy service fees using the dispensing claims in hospital and clinic outpatient pharmacies: national health insurance database between 2006 and 2012.
    Ha D; Song I; Lee EK; Shin JY
    BMC Health Serv Res; 2018 May; 18(1):327. PubMed ID: 29724220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Provider Perception of Pharmacy Services in the Patient-Centered Medical Home.
    Albanese NP; Pignato AM; Monte SV
    J Pharm Pract; 2017 Dec; 30(6):612-620. PubMed ID: 27887032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ReCAP: Pharmacists' Impact in Hematopoietic Stem-Cell Transplantation: Economic and Humanistic Outcomes.
    Alexander MD; Rao KV; Khan TS; Deal AM; Alexander MD; Rao KV; Khan TS; Deal AM
    J Oncol Pract; 2016 Feb; 12(2):147-8, e118-26. PubMed ID: 26787757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of pharmacist charges for medication therapy management services in an outpatient setting.
    Zingone MM; Malcolm KE; McCormick SW; Bledsoe KR
    Am J Health Syst Pharm; 2007 Sep; 64(17):1827-31. PubMed ID: 17724364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Best practices: improving patient outcomes and costs in an ACO through comprehensive medication therapy management.
    Brummel A; Lustig A; Westrich K; Evans MA; Plank GS; Penso J; Dubois RW
    J Manag Care Spec Pharm; 2014 Dec; 20(12):1152-8. PubMed ID: 25597053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transferring Key Success Factors from Ambulatory Care into the Community Pharmacy in the United States.
    Luli AJ; Awdishu L; Hirsch JD; Watanabe JH; Bounthavong M; Morello CM
    Pharmacy (Basel); 2021 Jun; 9(3):. PubMed ID: 34201476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Establishing pathways for access to pharmacist-provided patient care.
    Schommer JC; Doucette WR; Planas LG
    J Am Pharm Assoc (2003); 2015; 55(6):664-668. PubMed ID: 26547600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Redesigning ambulatory care business processes supporting clinical care delivery.
    Patterson C; Sinkewich M; Short J; Callas E
    J Ambul Care Manage; 1997 Apr; 20(2):37-52. PubMed ID: 10181605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Economic evaluation of pharmacy services--fact or fiction?
    George B; Silcock J
    Pharm World Sci; 1999 Aug; 21(4):147-51. PubMed ID: 10483601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.